3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one

C91H76N30O5 — CID 159753794

IUPAC3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one
SMILESCCN(CC)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.CCNC(=O)c1cncc(-c2cnc3n[nH]c(-c4nc5ccccc5[nH]4)c3c2)c1.CN(C)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.COc1ccccc1-c1ccc2c(-c3nc4ccccc4[nH]3)[nH]nc2n1.O=C1NCCc2nc3n[nH]c(-c4nc5ccccc5[nH]4)c3cc21
InChIInChI=1S/C21H17N7O.C20H15N5O.C18H18N6O.C16H12N6O.C16H14N6O/c1-2-23-21(29)14-7-12(9-22-10-14)13-8-15-18(27-28-19(15)24-11-13)20-25-16-5-3-4-6-17(16)26-20;1-26-17-9-5-2-6-12(17)14-11-10-13-18(24-25-19(13)21-14)20-22-15-7-3-4-8-16(15)23-20;1-3-24(4-2)18(25)11-9-12-15(22-23-16(12)19-10-11)17-20-13-7-5-6-8-14(13)21-17;23-16-8-7-9-13(15-19-11-3-1-2-4-12(11)20-15)21-22-14(9)18-10(8)5-6-17-16;1-22(2)16(23)9-7-10-13(20-21-14(10)17-8-9)15-18-11-5-3-4-6-12(11)19-15/h3-11H,2H2,1H3,(H,23,29)(H,25,26)(H,24,27,28);2-11H,1H3,(H,22,23)(H,21,24,25);5-10H,3-4H2,1-2H3,(H,20,21)(H,19,22,23);1-4,7H,5-6H2,(H,17,23)(H,19,20)(H,18,21,22);3-8H,1-2H3,(H,18,19)(H,17,20,21)
InChIKeyNDZKBUHEADDUFS-UHFFFAOYSA-N
MW1669.81 g/mol
LogP14.46
Rot. Bonds14

About 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one

3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one (PubChem CID 159753794) has the molecular formula C91H76N30O5 and a molecular weight of 1669.81 g/mol. Its IUPAC name is 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one.

Molecular Properties

Compound Name3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one
PubChem CID159753794
Molecular FormulaC91H76N30O5
Molecular Weight1669.81 g/mol
Exact Mass1668.66
IUPAC Name3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one
SMILESCCN(CC)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.CCNC(=O)c1cncc(-c2cnc3n[nH]c(-c4nc5ccccc5[nH]4)c3c2)c1.CN(C)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.COc1ccccc1-c1ccc2c(-c3nc4ccccc4[nH]3)[nH]nc2n1.O=C1NCCc2nc3n[nH]c(-c4nc5ccccc5[nH]4)c3cc21
InChIInChI=1S/C21H17N7O.C20H15N5O.C18H18N6O.C16H12N6O.C16H14N6O/c1-2-23-21(29)14-7-12(9-22-10-14)13-8-15-18(27-28-19(15)24-11-13)20-25-16-5-3-4-6-17(16)26-20;1-26-17-9-5-2-6-12(17)14-11-10-13-18(24-25-19(13)21-14)20-22-15-7-3-4-8-16(15)23-20;1-3-24(4-2)18(25)11-9-12-15(22-23-16(12)19-10-11)17-20-13-7-5-6-8-14(13)21-17;23-16-8-7-9-13(15-19-11-3-1-2-4-12(11)20-15)21-22-14(9)18-10(8)5-6-17-16;1-22(2)16(23)9-7-10-13(20-21-14(10)17-8-9)15-18-11-5-3-4-6-12(11)19-15/h3-11H,2H2,1H3,(H,23,29)(H,25,26)(H,24,27,28);2-11H,1H3,(H,22,23)(H,21,24,25);5-10H,3-4H2,1-2H3,(H,20,21)(H,19,22,23);1-4,7H,5-6H2,(H,17,23)(H,19,20)(H,18,21,22);3-8H,1-2H3,(H,18,19)(H,17,20,21)
InChIKeyNDZKBUHEADDUFS-UHFFFAOYSA-N
XLogP14.46
TPSA472.19 Ų
H-Bond Donors12
H-Bond Acceptors21
Rotatable Bonds14
Heavy Atoms126
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001669.81
LogP ≤ 514.46
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1021

Analyze 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one?
The IUPAC name of 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one (CID 159753794) is 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one.
What is the SMILES notation for 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one?
The canonical SMILES for 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one is CCN(CC)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.CCNC(=O)c1cncc(-c2cnc3n[nH]c(-c4nc5ccccc5[nH]4)c3c2)c1.CN(C)C(=O)c1cnc2n[nH]c(-c3nc4ccccc4[nH]3)c2c1.COc1ccccc1-c1ccc2c(-c3nc4ccccc4[nH]3)[nH]nc2n1.O=C1NCCc2nc3n[nH]c(-c4nc5ccccc5[nH]4)c3cc21.
What is the InChIKey of 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one?
The InChIKey is NDZKBUHEADDUFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17N7O.C20H15N5O.C18H18N6O.C16H12N6O.C16H14N6O/c1-2-23-21(29)14-7-12(9-22-10-14)13-8-15-18(27-28-19(15)24-11-13)20-25-16-5-3-4-6-17(16)26-20;1-26-17-9-5-2-6-12(17)14-11-10-13-18(24-25-19(13)21-14)20-22-15-7-3-4-8-16(15)23-20;1-3-24(4-2)18(25)11-9-12-15(22-23-16(12)19-10-11)17-20-13-7-5-6-8-14(13)21-17;23-16-8-7-9-13(15-19-11-3-1-2-4-12(11)20-15)21-22-14(9)18-10(8)5-6-17-16;1-22(2)16(23)9-7-10-13(20-21-14(10)17-8-9)15-18-11-5-3-4-6-12(11)19-15/h3-11H,2H2,1H3,(H,23,29)(H,25,26)(H,24,27,28);2-11H,1H3,(H,22,23)(H,21,24,25);5-10H,3-4H2,1-2H3,(H,20,21)(H,19,22,23);1-4,7H,5-6H2,(H,17,23)(H,19,20)(H,18,21,22);3-8H,1-2H3,(H,18,19)(H,17,20,21).
What are the key properties of 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one?
3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one has a molecular weight of 1669.81 g/mol, XLogP of 14.46, 14 rotatable bonds, 12 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1H-benzimidazol-2-yl)-N,N-diethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-N,N-dimethyl-2H-pyrazolo[3,4-b]pyridine-5-carboxamide;3-(1H-benzimidazol-2-yl)-6-(2-methoxyphenyl)-2H-pyrazolo[3,4-b]pyridine;5-[3-(1H-benzimidazol-2-yl)-2H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethylpyridine-3-carboxamide;3-(1H-benzimidazol-2-yl)-2,6,7,8-tetrahydropyrazolo[3,4-b][1,6]naphthyridin-5-one is sourced from PubChem (CID 159753794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).